Mark Edward Randall - Net Worth and Insider Trading
Mark Edward Randall Net Worth
The estimated net worth of Mark Edward Randall is at least $6,973 dollars as of 2024-06-18. Mark Edward Randall is the 10% Owner of TC BioPharm (Holdings) PLC and owns about 7,339 shares of TC BioPharm (Holdings) PLC (TCBP) stock worth over $6,973. Details can be seen in Mark Edward Randall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Edward Randall has not made any transactions after 2022-11-30 and currently still holds the listed stock(s).
Transaction Summary of Mark Edward Randall
Mark Edward Randall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Edward Randall owns 1 companies in total, including TC BioPharm (Holdings) PLC (TCBP) .
Click here to see the complete history of Mark Edward Randall’s form 4 insider trades.
Insider Ownership Summary of Mark Edward Randall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TCBP | TC BioPharm (Holdings) PLC | 2022-11-30 | 10 percent owner |
Mark Edward Randall Latest Holdings Summary
Mark Edward Randall currently owns a total of 1 stock. Mark Edward Randall owns 7,339 shares of TC BioPharm (Holdings) PLC (TCBP) as of November 30, 2022, with a value of $6,973.
Latest Holdings of Mark Edward Randall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TCBP | TC BioPharm (Holdings) PLC | 2022-11-30 | 7,339 | 0.95 | 6,973 |
Holding Weightings of Mark Edward Randall
Mark Edward Randall Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Edward Randall has made a total of 2 transactions in TC BioPharm (Holdings) PLC (TCBP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in TC BioPharm (Holdings) PLC is the acquisition of 3,500 shares on November 30, 2022, which cost Mark Edward Randall around $350,000.
Insider Trading History of Mark Edward Randall
- 1
Mark Edward Randall Trading Performance
GuruFocus tracks the stock performance after each of Mark Edward Randall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Edward Randall is -14.44%. GuruFocus also compares Mark Edward Randall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Edward Randall within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Edward Randall's insider trading performs compared to the benchmark.
Performance of Mark Edward Randall
Mark Edward Randall Ownership Network
Ownership Network List of Mark Edward Randall
Ownership Network Relation of Mark Edward Randall
Mark Edward Randall Owned Company Details
What does TC BioPharm (Holdings) PLC do?
Who are the key executives at TC BioPharm (Holdings) PLC?
Mark Edward Randall is the 10 percent owner of TC BioPharm (Holdings) PLC. Other key executives at TC BioPharm (Holdings) PLC include 10 percent owner Renaissance Capital Partners Ltd , 10 percent owner Diana Elizabeth Randall , and 10 percent owner Kenneth Edward Randall .
TC BioPharm (Holdings) PLC (TCBP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of TC BioPharm (Holdings) PLC (TCBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TC BioPharm (Holdings) PLC (TCBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TC BioPharm (Holdings) PLC (TCBP)'s detailed insider trading history can be found in Insider Trading Tracker table.
TC BioPharm (Holdings) PLC Insider Transactions
Mark Edward Randall Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Edward Randall. You might contact Mark Edward Randall via mailing address: C/o Renaissance Capital Partners Ltd, 42 Shad Thames, London X0 Se1 2yd.